Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015680
Filing Date
2025-06-04
Accepted
2025-06-04 20:00:15
Documents
1
Period of Report
2025-06-03

Document Format Files

Seq Description Document Type Size
1 form4-06042025_080607.html 4  
1 form4-06042025_080607.xml 4 4115
  Complete submission text file 0001415889-25-015680.txt   5602
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Issuer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address
Reumuth Mary (Reporting) CIK: 0001710969 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 251024727